fabry disease symptoms in the heart graphical image


Find out more about cardiac related signs and symptoms.

fabry disease symptoms in the kidneys graphical image


Find out more about renal related signs and symptoms.

fabry disease symptoms in the brain graphical image


Find out more about neurological related signs and symptoms.

In Fabry disease, the accumulation of glycosphingolipids (predominantly Gb3) results in a variety of clinical manifestations, which typically worsen over time1–3 and can include:


  • Left ventricular hypertrophy
  • Ischaemia
  • Enlarged left atrium
  • Heart valve abnormalities
  • Conduction disturbances and arrhythmias


  • Proteinuria
  • Progressive loss of renal function, leading to kidney failure
  • Renal cysts


  • Stroke
  • Dizziness


  • Abdominal cramping
  • Frequent bowel movements soon after eating
  • Diarrhoea
  • Nausea


  • Angiokeratoma

Peripheral nervous system

  • Acroparesthesia
  • Hypohidrosis
  • Intolerance to heat or cold


  • Neuropsychiatric and psychosocial issues
  • Fatigue (which can be extreme)

Signs & symptoms


Dyspnoea, chest pain, fainting and palpitations View more on cardiac symptoms


Renal abnormalities are very common and are referred to as Fabry nephropathy View more on renal symptoms


Altered blood flow to the brain, increased risk of stroke and exercise intolerance View more on neurological symptoms

Peripheral Nervous System

Acroparesthesia, hypohidrosis and heat intolerance



Gastrointestinal tract

Diarrhoea, pain, bloating and/or constipation


Hearing loss, tinnitus and vertigo


Corneal, retinal and lens problems

fabry disease signs & symptoms in the body graphical image

The progressive storage of Gb3 molecules leads to cellular dysfunction, triggering tissue inflammation and/or fibrosis.1,3,4 This is part of a cascade of events, including cell death, impaired energy metabolism, small vessel injury and tissue ischaemia.1 An important pathological consequence of these cellular changes is the development of irreversible cardiac and renal tissue fibrosis.1,5–7 The kidneys, heart and cerebrovascular system are considered to be the main organs affected;8,9 however, Fabry disease may affect additional organ systems.2

Fabry disease symptoms are almost always observed in males with the Fabry disease gene, although they vary in severity between individuals; in females, the expression of signs and symptoms is more variable than in males and the disease can be asymptomatic.1,2 Fabry disease typically presents later in females than in males and progresses at a slower rate.1,2,10 The reason for the variability in the expression of disease symptoms in females is not fully understood, but may be explained in part by the random inactivation of the X chromosome (lyonization) or additional mechanisms such as cross correction of the metabolic defect.1

Fabry disease significantly reduces life expectancy in both males and females.1,7,10‒13

Natural course of Fabry disease: Clinical sequelae in men

  • Multiple organ dysfunction, with number of organs involved rising with age1
  • Renal and cardiac signs and symptoms found in >50% of male patients >40 years of age1
  • Vascular signs and symptoms not generally reported in the first decade1
  • Neurological symptoms are commonly reported in male patients (up to 84%)1-3
  • Pain has an earlier onset in males than other signs and symptoms2
Natural course of Fabry disease symptoms: Clinical sequelae in men

Natural course of Fabry disease: Clinical sequelae in women

  • Female patients can exhibit significant signs and symptoms of Fabry disease1–3
  • Multiple organ dysfunction, with number of organs involved rising with age2
  • Most signs and symptoms develop by >30 years of age3
  • Pain is one of the most prevalent symptoms of Fabry disease and is reported to occur in ~65% of female patients4
Natural course of Fabry disease symptoms: Clinical sequelae in women

To learn more about the impact of Fabry disease on the heart and kidneys, watch this video:

Sign up to receive more information about Anderson-Fabry Disease

First Name
Last Name

With your permission, Shire would like to contact you by electronic means (such as email or SMS) with information about products and services that we feel may be of interest to you. You have the right to opt out of receiving such electronic communications, at any time, by contacting us. Depending on the country you reside in, Shire may be required by law to obtain your consent in order to be able to send such electronic communications to you.

I consent to be contacted by Shire by electronic means with information about Shire's products and services.
We encourage you to read our privacy policy.

Start typing and press Enter to search